Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Total Non-Current Liabilities of $60.83 billion in Q3 2026, down 16.5% from $72.83 billion a year earlier and down 0.2% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb reported Total Non-Current Liabilities of $66.49 billion, down 7.3% from FY2024.

  • Annual Total Non-Current Liabilities has a five-year compound annual growth rate of -1.8% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $71.75 billion in FY2024 (+21.1%), $59.25 billion in FY2023 (+0.2%), $59.11 billion in FY2022 (-10.4%) and $65.97 billion in FY2021 (-9.4%).
  • The Q3 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q4 2023.
  • On a year-over-year basis, Total Non-Current Liabilities has declined for four consecutive quarters, with an average decline of 4.6% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 35.9% in Q1 2024, against a decline of 16.5% in Q3 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $60.97 billion (Q2 2026), $61.52 billion (Q1 2026) and $66.49 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 102.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 117.60 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -36.84 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 96.04 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 60.83 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 60.83 Bn
Jun 30, 2026 60.97 Bn
Mar 31, 2026 61.52 Bn
Dec 31, 2025 66.49 Bn
Sep 30, 2025 72.83 Bn
Jun 30, 2025 72.25 Bn
Mar 31, 2025 70.50 Bn
Dec 31, 2024 71.75 Bn
Sep 30, 2024 71.74 Bn
Jun 30, 2024 72.58 Bn
Mar 31, 2024 75.75 Bn
Dec 31, 2023 59.25 Bn
Sep 30, 2023 56.00 Bn
Jun 30, 2023 55.56 Bn
Mar 31, 2023 55.73 Bn
Dec 31, 2022 59.11 Bn
Sep 30, 2022 58.78 Bn
Jun 30, 2022 61.06 Bn
Mar 31, 2022 64.08 Bn
Dec 31, 2021 65.97 Bn
API Access

Bristol Myers Squibb Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BMY&period=max&api_key=YOUR_API_KEY